Fact-checked by Grok 2 weeks ago

Gastric acid

Gastric acid, also known as acid, is a specialized digestive fluid secreted by the parietal cells in the of the lining, primarily composed of (HCl) that creates a highly acidic environment with a typically ranging from 1.5 to 3.5. This secretion forms the core component of gastric juice, which also includes water, , (a proteolytic ), gastric , and , all contributing to the 's role in initial food breakdown. The primary physiological functions of gastric acid involve protein digestion, defense, and nutrient . It denatures dietary proteins to make them more accessible to enzymatic cleavage, activates pepsinogen secreted by chief cells into active for hydrolyzing bonds, and provides an optimal low-pH milieu (around 2.0) for activity. Additionally, the acidic conditions eradicate most ingested and parasites, preventing infections, while facilitating the release and of minerals like iron and vitamins such as B12 through interactions with . Gastric acid secretion is tightly regulated through neural and hormonal mechanisms across three phases: cephalic (triggered by sight/smell of food via releasing ), gastric (stimulated by food in via distension and peptides releasing from G cells), and intestinal (modulated by entering ). The key stimulants— from antral G cells, from enterochromaffin-like cells, and from vagal nerves—act synergistically on parietal cells via receptors to activate the H+/K+-ATPase , which exchanges ions for to generate HCl. This dynamic control ensures acid production matches digestive needs, averaging 2-3 liters per day in adults under normal conditions.

Composition and Properties

Chemical Makeup

Gastric acid is primarily composed of hydrochloric acid (HCl), which constitutes the dominant component at concentrations typically ranging from 0.05 to 0.1 M in human gastric secretions, rendering it a strong acid capable of fully dissociating in solution. This HCl is the key acidic element, with the solution also containing water as the solvent, making up the bulk of the volume. The formation of HCl occurs within parietal cells of the gastric mucosa through a process involving the hydration of carbonic acid. Carbon dioxide (CO₂) and water (H₂O) react to form carbonic acid (H₂CO₃), catalyzed by the enzyme carbonic anhydrase, which then dissociates into hydrogen ions (H⁺) and bicarbonate ions (HCO₃⁻). The H⁺ ions are actively transported out of the cell into the gastric lumen via the H⁺/K⁺-ATPase proton pump, while chloride ions (Cl⁻) are secreted concurrently through chloride channels to combine with H⁺, forming HCl. This mechanism ensures the generation of a highly acidic environment. In addition to HCl, gastric acid includes minor ionic components such as (K⁺) at around 15–17 , sodium (Na⁺) at about 3–7 , and Cl⁻ balancing the cations at approximately 170 , which maintain electrochemical balance but do not significantly contribute to acidity. Parietal cells also secrete , a essential for absorption, present in trace amounts within the gastric juice. These elements are secondary to HCl, which defines the acid's primary chemical identity. The overall production can be summarized by the key reaction: \ce{CO2 + H2O ⇌ H2CO3 ⇌ H+ + HCO3-} where the H⁺ is extruded by the H⁺/K⁺-ATPase, establishing the acidic milieu.

Physical Characteristics

Gastric acid is a colorless, watery fluid produced by the parietal cells of the lining. Its appearance resembles a clear , with no inherent pigmentation, though it may take on hues from ingested materials or digestive processes . At body temperature (approximately 37°C), the of ranges from 1.004 to 1.010 g/cm³, making it slightly denser than pure water due to dissolved electrolytes and other solutes. The acidity of gastric acid is characterized by a typically ranging from 1.5 to 3.5 in the lumen, reflecting its role as a highly acidic . In the fasted state, the is around 1.7, while during following a , the initially rises due to buffering (reaching a of about 4.6) before acid intensifies, lowering it to approximately 2.1–2.8 over 1–2 hours. This variability underscores the dynamic nature of gastric acidity in response to physiological states. The low contributes to its corrosive properties, enabling it to denature proteins and damage unprotected tissues through and , though the mucosa is adapted to withstand such effects via protective barriers. Gastric acid exhibits high , generally near iso-osmotic to at 280–300 mOsm/L, arising from its concentration, including ions and other salts. This osmolarity enhances its corrosive potential by facilitating and tissue penetration in non-adapted environments. The of gastric acid is similar to that of , approximately 4.18 J/g·°C, reflecting its predominantly aqueous composition and allowing efficient in the gastric environment.

Production and Secretion

Cellular Mechanisms

Gastric acid secretion primarily occurs in the parietal cells, which are specialized epithelial cells located in the of the stomach's fundus and body regions. These cells are responsible for producing (HCl) through a series of coordinated intracellular and processes that generate and release protons and ions into the gastric . The parietal cells feature a highly invaginated apical forming canaliculi, which expand dramatically during active to facilitate the extrusion of acid. The core mechanism of acid generation begins intracellularly with the enzyme , which catalyzes the rapid conversion of and into (H₂CO₃), dissociating into (HCO₃⁻) and protons (H⁺). The protons are then actively transported across the apical into the canaliculi via the H⁺/K⁺-ATPase , a that exchanges intracellular H⁺ for extracellular K⁺ using , creating a steep against which H⁺ is secreted. Simultaneously, ions (Cl⁻) are released through apical chloride channels, such as the (CFTR), allowing Cl⁻ to efflux into the canaliculi where it combines with H⁺ to form HCl. This process ensures electroneutral secretion of the acid. To sustain these transport activities, the basolateral membrane of parietal cells houses the Na⁺/K⁺-ATPase, which pumps sodium ions out and potassium ions in, maintaining low intracellular and high concentrations essential for the ion gradients required by the apical pumps and channels. During stimulation, intracellular tubulovesicles containing H⁺/K⁺-ATPase and other components fuse with the apical membrane via , vastly increasing the secretory surface area—up to 10-fold—and enabling high-volume acid release into the . This dynamic membrane recycling is crucial for the cell's ability to switch between resting and secreting states.

Physiological Triggers

Gastric acid is initiated through three overlapping physiological phases—cephalic, gastric, and intestinal—that collectively contribute to the stomach's daily output of approximately 2 to 3 liters of , with peaking in the hours following a . These phases respond to sensory and cues, coordinating the activation of parietal cells in the to produce . The cephalic phase begins upon anticipation of , triggered by the sight, smell, or even thought of eating, and accounts for about 30% of total meal-stimulated acid secretion. This phase is mediated primarily by vagal nerve stimulation, which releases (ACh) onto muscarinic receptors on parietal cells and enterochromaffin-like (ECL) cells, initiating acid production before food reaches the . The gastric phase, representing roughly 60% of acid secretion, is activated once food enters the stomach, where mechanical distension of the gastric wall stimulates stretch receptors and chemical presence of peptides and excites mucosal chemoreceptors. These local stimuli trigger short neural reflexes via the and promote the release of from G cells in the , which further amplifies acid secretion through direct and indirect pathways. The intestinal phase provides a minor contribution of about 10% to overall acid secretion, occurring as partially digested enters the and stimulates enteroendocrine cells to release various hormones, such as cholecystokinin (CCK), which contribute to sustaining gastric acid output alongside inhibitory signals like . This phase includes both stimulatory and inhibitory components to fine-tune acid delivery to the , though its role diminishes rapidly to prevent excessive acidity. These phases are fine-tuned by local feedback mechanisms, such as somatostatin release from D cells in the , which provides paracrine inhibition to modulate acid output in response to luminal changes.

Regulation of Secretion

Stimulatory Pathways

Gastric acid secretion by parietal cells in the is primarily stimulated through three interconnected pathways involving , , and , each activating specific receptors and second messenger systems to enhance the activity of the H⁺,K⁺-ATPase . These pathways are triggered by physiological stimuli such as intake during the cephalic, gastric, and intestinal . Histamine, produced and released from enterochromaffin-like (ECL) cells in the oxyntic mucosa, binds to H₂ receptors on the basolateral of parietal cells. This interaction couples to Gₛ proteins, activating adenylate cyclase and resulting in increased intracellular cyclic AMP () levels. The elevated activates (PKA), which phosphorylates key proteins, including the H⁺,K⁺-ATPase, promoting its translocation from cytoplasmic tubulovesicles to the apical canalicular and thereby stimulating acid extrusion into the gastric lumen. Gastrin, released from G cells in the gastric , exerts its stimulatory effects both indirectly and directly. It binds to cholecystokinin-2 (CCK₂) receptors on ECL cells, prompting release that amplifies the H₂-mediated pathway. Additionally, gastrin acts directly on CCK₂ receptors on parietal cells, coupling to G_q proteins to activate , which generates (IP₃) and diacylglycerol, leading to an increase in cytosolic Ca²⁺ concentrations. This Ca²⁺ signaling mobilizes further intracellular stores and activates calmodulin-dependent kinases, enhancing function and acid secretion. Acetylcholine (ACh), released from postganglionic fibers of the , binds to M₃ muscarinic receptors on parietal cells. These G_q-coupled receptors stimulate , producing IP₃ and mobilizing Ca²⁺ from intracellular stores, which raises cytosolic Ca²⁺ levels and potentiates the activation of the apical . The , , and ACh pathways operate synergistically, with their combined activation—known as the triple pathway—amplifying gastric acid secretion up to 10-fold compared to maximal stimulation by any single mediator, ensuring robust digestive response to meals. This amplification arises from cross-talk between cAMP and Ca²⁺ signaling, where, for instance, 's cAMP elevation sensitizes parietal cells to Ca²⁺-dependent effects from and ACh.

Inhibitory Mechanisms

Somatostatin, secreted by D cells in the gastric and oxyntic mucosa, serves as the primary paracrine inhibitor of gastric acid secretion. It exerts its effects by binding to type 2 (SSTR2) on G cells and enterochromaffin-like (ECL) cells, thereby suppressing the release of and , respectively. This inhibition prevents excessive stimulation of parietal cells, maintaining a balance against the stimulatory pathways involving , , and . Additionally, somatostatin can directly inhibit parietal cell function by reducing cyclic AMP () levels. Prostaglandins, particularly prostaglandin E2 (PGE2), provide another key inhibitory mechanism by acting directly on parietal cells. PGE2 binds to EP3 receptors on these cells, leading to a decrease in intracellular cAMP levels, which antagonizes the stimulatory effects of histamine at H2 receptors. This reduction in cAMP impairs the activation of protein kinase A and subsequent proton pump activity, effectively blocking acid secretion in response to histamine-driven stimuli. Non-steroidal anti-inflammatory drugs (NSAIDs) that inhibit prostaglandin synthesis can thus exacerbate acid production, highlighting the protective role of endogenous prostaglandins. During the intestinal phase of digestion, hormones released from the further modulate gastric acid secretion to prevent duodenal overload. Secretin, triggered by low duodenal pH, and cholecystokinin (CCK), stimulated by fats and proteins, both promote the release of from D cells, indirectly inhibiting and secretion. This mediated inhibition ensures that acid output decreases as enters the , coordinating gastric emptying with duodenal processing capacity. A critical loop operates within the to autoregulate acid secretion based on luminal . When gastric pH falls below approximately 3, antral D cells increase release, which potently suppresses further secretion from G cells and, to a lesser extent, from ECL cells. This pH-dependent mechanism, involving both neural vagal reflexes and hormonal signals, rapidly shuts down activity to avoid excessive acidity that could damage the mucosa. In response to chronic stimuli such as prolonged hypergastrinemia, the undergoes adaptive changes to modulate acid secretion long-term. Sustained elevation of , often seen in conditions like chronic or long-term use, induces , increasing the number of acid-secreting cells. These adaptations help restore by compensating for initial hypersecretion, though they can contribute to pathological states if dysregulated.

Physiological Functions

Digestive Processes

Gastric acid plays a central role in initiating protein digestion within the by creating an acidic environment that activates pepsinogen, the inactive precursor secreted by chief cells, into the active enzyme . This autocatalytic process occurs at low levels, where hydrogen ions cleave the activation peptide from pepsinogen, enabling to hydrolyze dietary proteins into smaller and polypeptides. Once activated, preferentially cleaves peptide bonds adjacent to aromatic , breaking down complex proteins into fragments that are more accessible for subsequent enzymatic action in the . In addition to enzyme activation, gastric acid denatures ingested proteins by disrupting their and structures through of side chains and disruption of bonds. This unfolding exposes internal bonds that were previously shielded, making the proteins more susceptible to by and enhancing the overall efficiency of gastric . Denaturation is particularly crucial for tough dietary proteins, such as those from meat or plant sources, ensuring partial breakdown before the mixture enters the . Gastric acid also facilitates the solubilization of essential , converting insoluble forms of iron and calcium into bioavailable ions that can be absorbed in the . For instance, the acidic milieu reduces ferric iron (Fe³⁺) to ferrous iron (Fe²⁺) and dissolves calcium phosphates, preventing and promoting uptake via transporters like DMT1 for iron. This process is vital for maintaining , as deficiencies in gastric acid secretion, such as in hypochlorhydria, impair these absorptive steps. Beyond biochemical actions, gastric acid contributes to the physical of food by mixing with the bolus to form , a semi-liquid paste that ensures uniform exposure to . The acid's fluidity aids peristaltic contractions in liquefying solid food particles, typically reducing them to a consistency suitable for gradual release into the over 2–4 hours. Pepsin's proteolytic activity is optimized in the gastric environment at a pH of 1.5–2.5, where the enzyme's maximum (Vmax) increases due to enhanced and catalytic efficiency in the acidic milieu. At these conditions, the low stabilizes the active conformation of , allowing it to achieve peak rates before the mixture is neutralized downstream.

Protective Roles

Gastric acid serves a critical protective function through its bactericidal action, primarily due to the low environment it creates in the stomach, which effectively eliminates the majority of ingested pathogens. At a below 4.0, gastric acid kills approximately 99.9% of enteric bacteria, such as and species, within 30 minutes, acting as the stomach's primary innate defense mechanism against foodborne and waterborne microbes. By sterilizing the in the stomach, gastric acid prevents bacterial overgrowth in the , where nutrient-rich conditions could otherwise promote excessive microbial proliferation and disrupt normal absorption processes. In individuals with reduced gastric acidity, such as those with , bacterial survival rates increase dramatically, leading to higher colonization in the distal gut. Gastric acid contributes to the overall integrity of the gastric mucosal barrier by synergizing with the protective layer and movements, which together limit adhesion, penetration, and potential damage to the epithelial lining. The provides a physical barrier that traps microbes, while mechanically clears them, and the acid's low ensures most are inactivated before they can compromise the mucosa. Additionally, gastric acid facilitates the release of from food proteins through -mediated in the low-pH environment. , a secreted by parietal cells and resistant to acid and , binds to the free , protecting it from degradation and enabling its absorption in the via the cubam receptor. Hypochlorhydria impairs this process, as the higher reduces the dissociation of B12 from dietary complexes, underscoring acid's role in maintaining nutritional . The low pH of gastric acid also inactivates microbial from surviving pathogens, denaturing their proteins and halting enzymatic activities that could otherwise facilitate or production, thereby further reducing risk. This pH-dependent enzyme disruption complements the direct bactericidal effects, enhancing the stomach's barrier against opportunistic .

Neutralization and Homeostasis

Gastric Neutralization

Gastric neutralization refers to the processes within the that buffer (HCl) to safeguard the from self-digestion. Surface epithelial cells, including mucous cells, actively secrete ions (HCO₃⁻) into the overlying gel layer, establishing a protective gradient that transitions from approximately pH 2 in the acidic to near-neutral pH 7 at the epithelial surface. This secretion neutralizes hydrogen ions (H⁺) that diffuse into the , preventing their penetration to the underlying cells. The mucus layer, produced by gastric mucous cells, forms a viscous, adherent barrier that traps these secreted ions, enhancing their neutralizing capacity and limiting acid back-diffusion. This gel-like structure, primarily composed of such as MUC5AC, creates a stable diffusion barrier that maintains the integrity of the gradient even under high luminal acidity. Additionally, non-parietal secretions from and mucous cells, which include an alkaline component and constitute a significant portion of the total gastric fluid volume, further dilute and buffer the acidic environment. Tight junctions between epithelial cells play a crucial role in preventing the back-diffusion of H⁺ ions from the into the intercellular spaces, thereby preserving mucosal integrity. Prostaglandins, such as PGE₂, enhance these protective mechanisms by stimulating both production and secretion, amplifying the overall neutralizing capacity of the . The fundamental underlying this neutralization is the between luminal HCl and secreted HCO₃⁻: \text{HCl} + \text{HCO}_3^- \rightarrow \text{H}_2\text{CO}_3 \rightarrow \text{CO}_2 + \text{H}_2\text{O} This reaction rapidly converts acid into carbon dioxide and water, dissipating the threat to the epithelium without altering the overall gastric pH significantly.

Duodenal Protection

Upon entering the duodenum, the highly acidic chyme from the stomach, with a pH around 2, must be rapidly neutralized to prevent damage to the duodenal mucosa and to create an optimal environment for enzymatic digestion. The primary mechanism involves the secretion of bicarbonate-rich pancreatic juice, which can reach volumes of 1 to 2 liters per day, effectively raising the duodenal pH to 6–7. This alkaline fluid, produced by ductal epithelial cells in the pancreas, buffers the acid load and supports the activity of pancreatic enzymes like amylase and lipase. The process is hormonally regulated by enteroendocrine S cells in the duodenal mucosa, which detect low (below 4.5) and release into the bloodstream. then stimulates the to increase secretion from acinar and ductal cells, while also enhancing output from in the duodenal . These glands produce an alkaline rich in HCO₃⁻, forming a protective layer that further neutralizes acid and shields the . Bile, secreted by the liver and stored in the , contributes to this neutralization with its mildly alkaline (around 7–8), adding to the buffering capacity as it mixes with to aid in emulsification. Collectively, these mechanisms maintain a critical in the , preventing autodigestion of the intestinal lining; disruptions in this balance, such as impaired secretion, can lead to duodenal ulcers.

Clinical Significance

Associated Disorders

Gastroesophageal reflux disease () arises from excessive gastric acid refluxing into the , leading to mucosal erosion and inflammation known as reflux esophagitis. This condition affects approximately 20% of adults in Western populations, with symptoms including and regurgitation exacerbated by acid exposure. Peptic ulcers result from imbalances in gastric acid production that erode the protective mucosal lining, primarily due to infection or (NSAID) use. H. pylori is a major cause, accounting for 50–90% of duodenal ulcers and 40–80% of gastric ulcers, though rates have declined in regions with effective eradication programs by damaging the mucosa and promoting acid hypersecretion, while NSAIDs inhibit protective synthesis, increasing ulcer risk in 10-15% of chronic users in certain populations. The lifetime prevalence of is estimated at 5-10% globally. Zollinger-Ellison syndrome is a rare disorder caused by gastrin-secreting tumors (gastrinomas), resulting in marked gastric acid hypersecretion and recurrent, refractory peptic ulcers often located in atypical sites such as the distal or . Excess stimulates parietal cells to produce up to 10 times normal acid levels, leading to severe ulceration in over 90% of cases. Achlorhydria, characterized by absent or severely reduced gastric acid secretion, can stem from autoimmune destruction of parietal cells (as in ) or drug-induced inhibition such as prolonged use, increasing susceptibility to enteric infections and nutrient . Hypoacidity impairs iron and absorption, contributing to B12 deficiency in up to 20% of affected individuals with autoimmune . Barrett's esophagus develops as a complication of chronic , where prolonged acid and exposure induces metaplastic changes in the esophageal lining, replacing squamous with intestinal-type mucosa. This affects 10-15% of individuals with longstanding symptoms.

Diagnostic and Therapeutic Approaches

Diagnostic approaches to gastric acid-related conditions primarily involve assessing acid secretion levels and evaluating mucosal integrity. The 24-hour ambulatory is considered the gold standard for diagnosing (), as it quantifies the frequency and duration of acid exposure in the by detecting below 4, allowing correlation of symptoms with reflux events. Gastric acid output tests, such as the stimulation test combined with levels, measure basal and maximal acid secretion rates through blood sampling and gastric assessment, providing insight into hypersecretory states like Zollinger-Ellison syndrome. Upper endoscopy () is essential for visualizing mucosal damage, including erosive , , or peptic ulcers caused by excess acid, and can guide for complications like infection. Therapeutic strategies aim to reduce acid production, neutralize existing acid, or address underlying causes to manage conditions such as peptic ulcers and . Proton pump inhibitors (PPIs), exemplified by omeprazole, irreversibly inhibit the H+/K+-ATPase in parietal cells, suppressing gastric acid secretion by over 90% and promoting mucosal healing. H2-receptor antagonists like famotidine competitively block at H2 receptors on parietal cells, reducing acid output by 50-70% and offering an alternative for milder cases or PPI intolerance. Antacids containing (CaCO3) provide rapid, symptomatic relief by chemically neutralizing gastric acid, raising intragastric and alleviating within minutes, though their effect is short-lived. For acid-related disorders linked to H. pylori, such as duodenal ulcers, eradication typically involves a combination of (e.g., , amoxicillin, ) with a for 10-14 days, achieving eradication rates of 80-90% and preventing recurrence. However, rising antibiotic resistance has reduced eradication rates in some regions, with guidelines now recommending bismuth-based quadruple to achieve >90% success. Surgical interventions are reserved for refractory cases; , by severing vagal nerves to diminish stimulation of acid secretion, is used in hypersecretory syndromes to reduce basal and stimulated output. Fundoplication, particularly the laparoscopic Nissen procedure, reinforces the lower esophageal sphincter to prevent reflux in severe , with long-term symptom control in over 80% of patients.

Historical Development

Early Discoveries

The concept of gastric acid traces its origins to ancient medical theories, particularly those of around 400 BCE, who described the stomach's role in as involving the transformation of food through the body's four humors—, , yellow bile, and black bile—with yellow bile acting as a crucial gastric fluid that initiated the breakdown of ingested matter into vital essences. This humoral framework posited as a qualitative process of heating and mixing rather than a specific , influencing Western for centuries. In the , experimental approaches began to reveal the acidic nature of gastric s. René-Antoine Ferchault de Réaumur conducted pioneering studies in 1752 using a tame , feeding it small metal tubes containing ; the recovered tubes held partially digested immersed in an acidic fluid, leading Réaumur to conclude that the actively secreted a corrosive liquid essential for , distinct from mere mechanical churning. This work shifted views from passive to active , though the exact remained unclear. A major breakthrough came in 1824 when English physician and chemist William Prout isolated (HCl) from human gastric juice obtained during cases of dyspepsia, using and chemical assays to demonstrate its presence as free HCl rather than combined forms. Prout's analysis showed that gastric juice in its natural state contained this , capable of dissolving proteins and resisting , thus proving its inorganic chemical nature and refuting earlier notions that it resembled organic acids like or derived from food . Prior to Prout, misconceptions persisted that the stomach's acidity arose from ingested sour substances, such as -like fluids, rather than an endogenous secretion. Building on these foundations, German physiologist discovered as the key in gastric juice in 1836, isolating it from stomach secretions and demonstrating its proteolytic activity in the presence of acid. French physiologist advanced understanding in the 1850s through experiments on gastric , elucidating how HCl facilitated the of proteins into peptides and . Bernard's work, detailed in studies using animal models like dogs with fistulas, emphasized the synergistic role of acid and in chemical , solidifying the stomach's secretory mechanism as a cornerstone of .

Key Scientific Advances

In the early 20th century, the physiological effects of histamine, including its stimulation of gastric acid secretion, were first elucidated by Henry Hallett Dale and P.P. Laidlaw through experiments demonstrating its vasoactive and secretory properties in animal models. This discovery laid the groundwork for understanding histamine as a key regulator of parietal cell function, though its specific receptor subtypes remained unidentified for decades. Building on this, the identification of histamine H2 receptors in the 1970s by James W. Black and colleagues revolutionized the field, as these receptors were shown to mediate histamine's stimulatory effect on gastric acid production via cyclic AMP signaling in parietal cells. The development of selective H2 receptor antagonists, such as cimetidine in 1973, provided the first targeted pharmacological inhibition of acid secretion, marking a shift from symptomatic treatments to mechanism-based therapies. A pivotal biochemical advance occurred in 1976 when George Sachs and collaborators isolated and characterized the gastric H+/K+ ATPase from hog , confirming it as the terminal enzyme responsible for active transport into the lumen. This electroneutral ATP-driven exchanger exchanges intracellular H+ for extracellular K+, enabling the highly acidic environment of the . The isolation paved the way for proton pump inhibitors (PPIs), with omeprazole emerging in 1984 as the first compound to irreversibly bind and inhibit the pump's catalytic subunit, achieving profound and sustained suppression of acid output in clinical trials. Omeprazole's introduction transformed peptic ulcer management by promoting rapid healing and reducing recurrence rates, with subsequent PPIs like and refining this class for broader gastrointestinal applications. In 1982, Barry J. Marshall and J. Robin Warren identified as a primary etiological agent in and peptic ulcers, challenging the prevailing view that stress and diet were the main causes; their culture of the bacterium from gastric biopsies and self-experimentation by Marshall demonstrated its role in inducing inflammation and acid-related damage. This microbiological breakthrough, validated through and large-scale eradication studies, earned them the 2005 Nobel Prize in Physiology or Medicine and shifted treatment paradigms toward therapies combined with acid suppression. During the 2000s, genetic studies advanced the molecular understanding of function, with models revealing the essential roles of ion channels such as KCNQ1 and ClC-2 in maintaining apical K+ conductance and Cl- recycling necessary for sustained acid secretion. For instance, ClC-2 ablation led to reduced numbers and impaired H+/K+ ATPase activity, highlighting these channels' contributions to acid . Concurrently, research established gastric acid's role in modulating the gastric , as its bactericidal properties limit pathogenic overgrowth while permitting a core commensal community dominated by genera like and , thereby influencing downstream intestinal microbial composition and preventing . Post-2010 investigations have uncovered gastric acid's broader implications in systemic physiology, particularly its indirect influence on the gut-brain axis through microbiome regulation; alterations in acid secretion, often via PPI use, reshape microbial profiles that affect vagal signaling and neurotransmitter production, contributing to mood disorders and stress responses in preclinical models. Similarly, emerging links to immunotherapy highlight how acid-mediated microbial shifts can enhance or impair immune checkpoint inhibitor efficacy in gastric cancer, with studies showing that PPI-induced microbiome dysbiosis correlates with reduced T-cell infiltration and poorer responses to PD-1/PD-L1 blockade in clinical cohorts. These insights underscore acid's role in integrating gastrointestinal, neurological, and immunological networks.

References

  1. [1]
    Physiology, Stomach - StatPearls - NCBI Bookshelf - NIH
    Jul 17, 2023 · Hydrochloric acid (HCl), the main constituent of gastric acid, is secreted by parietal cells. The hydrogen (H) and chloride (Cl) components of ...Missing: composition | Show results with:composition
  2. [2]
    Gastric acid level of humans must decrease in the future - PMC - NIH
    Nov 21, 2020 · The pH of gastric acid in humans is 1.5-2.0. According to a report summarized by Beasley et al[6], the pH level is much lower than that of most ...
  3. [3]
    Physiology, Pepsin - StatPearls - NCBI Bookshelf - NIH
    May 1, 2023 · Parietal cells within the stomach lining secrete hydrochloric acid that lowers the pH of the stomach. A low pH (1.5 to 2) activates pepsin.
  4. [4]
    The Phylogeny and Biological Function of Gastric Juice ...
    Gastric juice is a unique combination of hydrochloric acid (HCl), lipase, and pepsin. Acidic gastric juice is found in all vertebrates, and its main ...
  5. [5]
    In brief: How does the stomach work? - InformedHealth.org - NCBI
    Aug 5, 2024 · The hydrochloric acid breaks down the food, and the digestive enzymes split up the proteins in the food. The acid also kills bacteria. Some of ...Missing: physiology | Show results with:physiology
  6. [6]
    The Physiology of the Gastric Parietal Cell - PMC - PubMed Central
    Parietal cells are responsible for gastric acid secretion, which aids in the digestion of food, absorption of minerals, and control of harmful bacteria.
  7. [7]
    Regulation of gastric acid secretion - PubMed
    The three stimulants of gastric acid secretion likely to have physiological roles in regulation of secretion are acetylcholine, gastrin, and histamine.
  8. [8]
    Regulation of gastric acid secretion - PubMed
    The main stimulants of acid secretion from the parietal cell are histamine, gastrin, and acetylcholine. Histamine, released from fundic enterochromaffin-like ...
  9. [9]
    The Parietal Cell: Mechanism of Acid Secretion
    For example, the low amounts of histamine released constantly from mast cells in the gastric mucosa only weakly stimulate acid secretion, and similarly for low ...
  10. [10]
    Hydrochloric Acid - Occupational Exposures to Mists and Vapours ...
    The adult human gastric mucosa produces about 1.5 1 per day of gastric juices with a normal acid concentration of 0.05–0.10 N (Rosenberg, 1980).
  11. [11]
    Quantification of swallowed saliva in aspirated gastric juice - PubMed
    Previous evidence suggests that primary gastric acid secretion has an electrolyte composition of [H+] 145, [Na+] 7, [K+] 17 and [Cl] 170 mmol/l, and that ...
  12. [12]
    All About pH for Stomach Acid - Healthline
    Apr 14, 2022 · Stomach acid, or gastric acid, is a watery, colorless fluid that's produced by your stomach's lining. It's highly acidic and helps break down ...
  13. [13]
    Advanced oral drug delivery systems for gastrointestinal targeted ...
    May 30, 2025 · Buoyancy (floating) property of ODDS in gastric juice​​ The density of gastric juice ranges from 1.004 to 1.010 g/mL. If the density of an ODDS ...
  14. [14]
    Upper gastrointestinal (GI) pH in young, healthy men and women
    In the fasted state, the median gastric pH was 1.7 and the median duodenal pH was 6.1.Missing: range | Show results with:range<|control11|><|separator|>
  15. [15]
    Osmotic concentration of the gastric juice of dogs - PubMed
    2. The osmolality of the blood that passes through the gastric mucosa increases during secretion of acid juice.3. The amount of water that should be removed ...Missing: pressure | Show results with:pressure<|separator|>
  16. [16]
    Histology, Parietal Cells - StatPearls - NCBI Bookshelf - NIH
    Harbored in the gastric glands of the fundus and body, parietal cells are considered to be dynamic, as they undergo morphological transition during the resting ...Introduction · Function · Tissue Preparation · Microscopy, Electron
  17. [17]
    Acid secretion and the H,K ATPase of stomach - PMC
    It appears that gastrin and acetylcholine exert their effects on acid secretion mainly by stimulation of histamine release from the enterochromaffin-like (ECL) ...
  18. [18]
    In Pursuit of the Parietal Cell – An Evolution of Scientific ... - Frontiers
    To maintain electroneutral acid secretion, chloride is also apically secreted along with hydrogen, generating HCl. On the apical side, the CFTR allows for ...
  19. [19]
    Role of potassium in acid secretion - Baishideng Publishing Group
    Sep 14, 2005 · The H+,K+-ATPase located on the apical membrane of the parietal cell exchanges H+ for K+. K+ is recycled from the canaliculus into the cytoplasm ...
  20. [20]
    Gastric acid secretion from parietal cells is mediated by a ... - NIH
    Gastric acid secretion by parietal cells requires trafficking and exocytosis of H-K-ATPaserich tubulovesicles (TVs) toward apical membranes in response to ...
  21. [21]
    Do We Need Gastric Acid? | Digestion - Karger Publishers
    Jul 2, 2008 · Given the large volume of gastric acid secretions (1.5–2.5 liters/day), efficient feedback mechanisms are mandatory to ensure effective ...
  22. [22]
    Physiology, Gastrointestinal Nervous Control - StatPearls - NCBI - NIH
    The first phase of gastric secretion is the cephalic phase. In this phase, a person sees, smells, or thinks about food, activating an area in the medulla ...
  23. [23]
    Stomach Acid Secretion - an overview | ScienceDirect Topics
    The cephalic phase of gastric acid secretion results from olfactory, visual ... The intestinal phase accounts for up to 10% of gastric acid secretion ...
  24. [24]
    Entero-oxyntin: a stimulant of gastric acid secretion ... - PubMed
    A peptide that further augments gastric acid secretion in cats, maximally stimulated by pentagastrin, was identified in porcine upper small intestine.
  25. [25]
    Analysis of Somatostatin-Secreting Gastric Delta Cells according to ...
    May 8, 2020 · D-cells produce somatostatin, the main paracrine inhibitor of acid secretion and GI motility [6]. Somatostatin influences gastric motility, ...
  26. [26]
    THE PHARMACOLOGY OF THE GASTRIC ACID PUMP: The H+,K+ ...
    Histamine elevates cAMP and Ca2+ in the parietal cell, whereas acetylcholine and gastrin elevate only calcium in the parietal cell. Permissive interactions may ...
  27. [27]
    Differentiation of the Gastric Mucosa I. Role of histamine in control of ...
    Gastric acid secretion is stimulated or inhibited by endocrine, paracrine, and neurocrine signals via at least three messenger pathways; gastrin-histamine, CCK- ...
  28. [28]
    Protein acidification and hydrolysis by pepsin ensure efficient trypsin ...
    Apr 24, 2021 · Abstract. Enzyme-catalysed hydrolysis is important in protein digestion. Protein hydrolysis is initiated by pepsin at low pH in the stomach.
  29. [29]
    Denaturation - an overview | ScienceDirect Topics
    Indeed, stomach acid denatures dietary protein so that the digestive enzymes—pepsin, trypsin, and chymotrypsin—can hydrolyze dietary proteins to amino acids.Missing: gastric | Show results with:gastric
  30. [30]
    Biochemistry, Iron Absorption - StatPearls - NCBI Bookshelf - NIH
    Gastric acid production plays a key role in plasma iron homeostasis. When proton-pump inhibiting drugs such as omeprazole are used, iron absorption is ...
  31. [31]
    Gastric Acid, Calcium Absorption, and Their Impact on Bone Health
    This article reviews the physiology of gastric acid secretion, intestinal calcium absorption, and their respective neuroendocrine regulation
  32. [32]
    Low gastric hydrochloric acid secretion and mineral bioavailability
    It has been established that low hydrochloric acid secretion can lead to decreased absorption of ferric iron.
  33. [33]
    Revisiting the enzymatic kinetics of pepsin using isothermal titration ...
    Jun 4, 2018 · We found that pepsin has a higher catalytic rate at lower pH, while its affinity to substrate is lower. At the same pH, pepsin has lower ...
  34. [34]
    Gastric Acid Barrier to Ingested Microorganisms in Man - PubMed
    At pH less than 4.0, 99.9% of the bacteria were killed within 30 minutes. The presence of profuse bacterial flora, including coliforms, found in markedly acid- ...
  35. [35]
    In Vitro Killing of Nosocomial Pathogens by Acid and Acidified Nitrite
    Gastric acid may provide an important host defense by killing ingested pathogens (5). For example, normal gastric acidity kills more than 99.9% of several gram ...
  36. [36]
    The role of gastric acid in preventing foodborne disease and how ...
    The secretion of hydrochloric acid by the stomach plays an important role in protecting the body against pathogens ingested with food or water.Missing: article | Show results with:article
  37. [37]
    Gastric mucosal defence mechanisms: a brief review - PubMed
    Several mucosal defence mechanisms protect the stomach against hydrochloric acid and noxious agents. The pre-epithelial protection is made up by the mucus- ...Missing: peristalsis | Show results with:peristalsis
  38. [38]
    Physiology, Gastric Intrinsic Factor - StatPearls - NCBI Bookshelf
    It plays a crucial role in the transportation and absorption of the vital micronutrient vitamin B12 (cobalamin, Cbl) by the terminal ileum. Insufficiency of ...Introduction · Cellular Level · Mechanism · Pathophysiology
  39. [39]
    Vitamin B12 deficiency induced by the use of gastric acid inhibitors
    Vitamin B12 malabsorption can occur from hypochlorhydria induced by the use of gastric acid inhibitors, specifically proton pump inhibitors (PPIs) and histamine ...
  40. [40]
    Surviving the Acid Test: Responses of Gram-Positive Bacteria to ...
    It has also been observed that neutralization of acid by food or bicarbonate decreases the infectious dose; for example, an increase in the pH of the stomach ...
  41. [41]
    Coping with low pH: molecular strategies in neutralophilic bacteria
    As part of their life cycle, neutralophilic bacteria are often exposed to varying environmental stresses, among which fluctuations in pH are the most frequent.
  42. [42]
    Role of mucus layers in gut infection and inflammation - PMC
    The attached inner mucus layer maintains a pH gradient with a pH of 2 at the lumen and 7 at the epithelial surface [32]. Few bacteria have developed ...
  43. [43]
    Gastroduodenal mucus bicarbonate barrier: protection against acid ...
    The primary function of the mucosal bicarbonate secretion is to neutralize acid diffusing into the mucus gel layer and to be quantitatively sufficient to ...
  44. [44]
    The gastrointestinal mucus system in health and disease - PMC
    Like the colon, the stomach has a two-layered mucus system. The inner mucus layer, built around MUC5AC, acts as a diffusion barrier for hydrochloric acid. The ...
  45. [45]
    Gastric mucus and bicarbonate secretion in relation to mucosal ...
    The magnitude of stimulated gastric bicarbonate secretion is 5 to 10% of maximal acid secretion for a given surface area of mucosa. Stimulants of gastric ...
  46. [46]
    Role of endogenous prostaglandins in gastric secretion ... - PubMed
    Exogenous prostaglandins inhibit acid secretion, stimulate mucus and bicarbonate secretion, alter mucosal blood flow, and provide dramatic protection.
  47. [47]
    Epithelial carbonic anhydrases facilitate PCO2 and pH regulation in ...
    The duodenum is the site of mixing of massive amounts of gastric H+ with secreted HCO3−, generating CO2 and H2O accompanied by the neutralization of H+.Equilibrated High Co... · Results · Premixed SolutionMissing: H2CO3 H2O
  48. [48]
    Physiology, Secretin - StatPearls - NCBI Bookshelf - NIH
    May 1, 2023 · [12] Secretin increases bicarbonate secretion from duodenal Brunner's gland as well; this mechanism buffers the acidity from chyme and reduces ...
  49. [49]
    Defective dietary fat processing in transgenic mice lacking ...
    In humans, 1.5–2.0 liters of bicarbonate-rich fluid are secreted by the pancreas, and 0.5–1.0 liters of bile are secreted by the liver.
  50. [50]
    Pancreatic Bicarbonate Secretion Involves Two Proton Pumps - PMC
    Pancreas secretes fluid rich in digestive enzymes and bicarbonate. The alkaline secretion is important in buffering of acid chyme entering duodenum and for ...
  51. [51]
    Pleiotropic Effects of Secretin: A Potential Drug Candidate in the ...
    Secretin also neutralizes the acidic contents of the duodenal lumen by stimulating pancreatic acinar cells and duodenal Brunner's glands to produce bicarbonate ...
  52. [52]
    Anatomy, Abdomen and Pelvis, Small Intestine - StatPearls - NCBI
    Feb 18, 2025 · Brunner glands secrete bicarbonate into the duodenum to neutralize stomach acid before chyme reaches the jejunum. The duodenum and upper ...
  53. [53]
    Physiology, Bile - StatPearls - NCBI Bookshelf
    Sep 12, 2022 · Provides an alkaline fluid in the duodenum to neutralize the acidic pH of the chyme that comes from the stomach. It provides bactericidal ...Missing: gastric | Show results with:gastric
  54. [54]
    Helicobacter pylori: the primary cause of duodenal ulceration ... - NIH
    The long held concept that duodenal ulceration is the result of a combination of increased acid output together with factors such as reduced bicarbonate in the ...
  55. [55]
    Gastroesophageal Reflux Disease (GERD) - StatPearls - NCBI - NIH
    Jul 6, 2025 · Reflux esophagitis occurs in patients with GERD when toxic substances, including gastric acid, pepsin, and bile salts, come into contact ...Introduction · Etiology · Epidemiology · Treatment / Management
  56. [56]
    Gastroesophageal reflux disease: Important considerations for the ...
    It is highly prevalent worldwide with a prevalence of 10%-20% in the western world[1-4]. It is estimated that GERD affects 18.6 million people in the United ...<|control11|><|separator|>
  57. [57]
    Peptic Ulcer Disease - StatPearls - NCBI Bookshelf - NIH
    Helicobacter Pylori-Associated PUD​​ This bacterium is responsible for 90% of duodenal ulcers and 70% to 90% of gastric ulcers. H. pylori infection is more ...
  58. [58]
    Interaction between Helicobacter pylori infection, nonsteroidal anti ...
    NSAIDs have emerged as one of the most important cause of peptic ulcer complications in many developed countries where the incidence of H. pylori-related ulcer ...
  59. [59]
    Zollinger-Ellison syndrome - Symptoms and causes - Mayo Clinic
    Nov 5, 2024 · Increased gastrin causes the stomach to make far too much acid. The excess acid then leads to peptic ulcers and sometimes to diarrhea. Besides ...
  60. [60]
    Gastrinoma - StatPearls - NCBI Bookshelf - NIH
    Feb 19, 2025 · Gastrinomas are rare neuroendocrine tumors that cause excess gastrin secretion, leading to ZES, characterized by severe peptic ulcers, ...
  61. [61]
    Achlorhydria - StatPearls - NCBI Bookshelf - NIH
    Achlorhydria is a condition in which the stomach does not produce hydrochloric acid, one of the components of gastric acid.
  62. [62]
    Autoimmune Gastritis and Hypochlorhydria: Known Concepts from a ...
    Jun 21, 2024 · Autoimmune atrophic gastritis is an immune-mediated disease resulting in autoimmune destruction of the specialized acid-producing gastric parietal cells.
  63. [63]
    Barrett Esophagus - StatPearls - NCBI Bookshelf
    May 26, 2025 · Most patients with Barrett esophagus will exhibit symptoms of GERD, such as heartburn (retrosternal burning), especially after eating. Acid ...
  64. [64]
    Barrett's esophagus - Symptoms and causes - Mayo Clinic
    Feb 8, 2023 · In some people, this GERD may trigger a change in the cells lining the lower esophagus, causing Barrett's esophagus.Missing: exposure | Show results with:exposure
  65. [65]
    Esophageal pH Monitoring - StatPearls - NCBI Bookshelf - NIH
    Ambulatory esophageal pH testing is done with a wireless pH capsule or a traditional pH probe and is the gold standard test for GERD diagnosis.
  66. [66]
    Advancements in the use of 24-hour impedance-pH monitoring for ...
    24-h impedance-pH monitoring represents the best diagnostic tool to detect abnormal reflux and to correlate symptoms to reflux episodes.
  67. [67]
    Continuous intravenous pentagastrin as a stimulant of maximal ...
    Johnston D., Jepson K. Use of pentagastrin in a test of gastric acid secretion. Lancet. 1967 Sep 16;2(7516):585–588. doi: 10.1016/s0140-6736(67)90739-8 ...
  68. [68]
    Pharmacology and clinical efficacy of ranitidine, a new H2-receptor ...
    It is more potent than cimetidine in inhibiting gastric acid secretion and lacks cimetidine's anti-androgenic and hepatic microsomal enzyme inhibiting effects.
  69. [69]
    Gastroesophageal reflux disease (GERD) - Diagnosis and treatment
    If stomach acid washes back into the esophagus, it can cause discomfort and may lead to precancerous changes in the lining of the esophagus.
  70. [70]
    Diagnosis and treatment of gastroesophageal reflux disease - PMC
    The diagnosis of GERD is typically made by a combination of clinical symptoms, response to acid suppression, as well as objective testing with upper endoscopy ...Diagnosis · Treatment · Medical Therapy
  71. [71]
    Omeprazole - StatPearls - NCBI Bookshelf - NIH
    Omeprazole is a proton-pump inhibitor used to manage and treat several conditions, including uncomplicated heartburn, peptic ulcer disease, gastrointestinal ...Continuing Education Activity · Indications · Mechanism of Action · Administration
  72. [72]
    Proton pump inhibitors: Review of reported risks and controversies
    1 PPIs act on the gastric acid production by inhibition of the gastric H+/K+‐ATPase via covalent binding to cysteine residue of this proton pump, affecting the ...
  73. [73]
    H2 Blockers - StatPearls - NCBI Bookshelf - NIH
    Aug 11, 2024 · H2 receptor blockers, or histamine-2 receptor antagonists (H2RAs), are gastric acid-suppressing agents frequently used to treat various gastric conditions.
  74. [74]
    Onset of acid-neutralizing action of a calcium/magnesium carbonate ...
    Mar 6, 2021 · Our data confirm the high efficacy and fast onset of acid-neutralizing action of Rennie, which begins to work within seconds.Outcomes Assessed · Acid Neutralization Effects · Pepsin ActivityMissing: duodenum | Show results with:duodenum<|control11|><|separator|>
  75. [75]
    Antacids - StatPearls - NCBI Bookshelf - NIH
    Aug 8, 2023 · The antacids act by neutralizing the acid in the stomach and by inhibiting pepsin, which is a proteolytic enzyme. Each of these cationic salts ...
  76. [76]
    Helicobacter Pylori: A Review of Current Treatment Options in ...
    Dec 6, 2022 · Though widely considered the most effective antimicrobial agent for treating and eradicating H. pylori, the use of clarithromycin is not without ...
  77. [77]
    A New Era in Helicobacter pylori Treatment - NIH
    Mar 12, 2023 · This review article provides an extensive overview of H. pylori antibiotic resistance and future treatment possibilities.
  78. [78]
    Gastric Hypersecretory States: Investigation and Management - PMC
    The gastric phase of gastric acid secretion occurs with the entry of nutrients into the gastrointestinal tract. Gastrin, released by antral G cells, is ...
  79. [79]
    Nissen Fundoplication - StatPearls - NCBI Bookshelf - NIH
    Anti-reflux surgery generally includes a fundoplication, which is a technique to recreate lower esophageal sphincter pressure by wrapping the fundus of the ...
  80. [80]
    Laparoscopic fundoplication for gastroesophageal reflux disease - NIH
    Laparoscopic fundoplication is the standard surgical treatment for GERD. It is highly effective in curing GERD with a 80% success rate at 20-year follow-up.
  81. [81]
    Ancient Theory of Elements and Humors
    Hippocrates theorized that humors were set in motion inner air and innate heat. They traveled through the veins to different organs of the body. The blood ...
  82. [82]
    a journey through time in quest for the stomach's secretion - PMC - NIH
    The first experiments​​ René Antoine Ferchault de Réaumur (1683-1757), experimenting with a tame buzzard which he fed small hollow metal tubes containing a ...Missing: 1752 source
  83. [83]
    III. On the nature of the acid and saline matters usually existing in the ...
    This illustrious philosopher concluded, from his numerous experiments, that the gastric fluids, when in a perfectly natural state, are neither acid nor alkaline ...
  84. [84]
    None
    Nothing is retrieved...<|separator|>
  85. [85]
    Histamine and gut mucosal immune regulation - Wiley Online Library
    Nov 29, 2013 · Soon afterward in 1910, Dale and Laidlaw reported the first biological functions of histamine, whereby they recognized that histamine had the ...
  86. [86]
    Histamine and its receptors
    This article reviews the development of our knowledge of the actions of histamine which have taken place during the course of the 20th century.
  87. [87]
    Characterization and development of cimetidine as a histamine H2 ...
    The evidence suggests that cimetidine inhibits gastric acid secretion through blockade of histamine HZ-receptors in the gastric mucosa. Cimetidine has been ...
  88. [88]
    The gastric HK-ATPase: structure, function, and inhibition - PMC - NIH
    In 1976, it was shown that gastric acid secretion was due to the action of an electroneutral ATP-dependent hydrogen–potassium exchanger [41]. The H,K-ATPase is ...
  89. [89]
    The discovery and development of the proton pump inhibitor
    ... Omeprazole, the first proton pump inhibitor. Med Res Rev 10 ... (1984) Gastric acid secretion and duodenal ulcer healing during treatment with omeprazole.
  90. [90]
    Press release: The Nobel Prize in Physiology or Medicine 2005
    Oct 3, 2005 · In 1982, when this bacterium was discovered by Marshall and Warren, stress and lifestyle were considered the major causes of peptic ulcer ...
  91. [91]
    Helicobacter pylori: A Nobel pursuit? - PMC - NIH
    In 2005, Barry Marshall and Robin Warren were awarded the Nobel prize in Physiology for their pioneering work on Helicobacter pylori.
  92. [92]
    Channel Disrupts Mouse Gastric Parietal Cell Acid Secretion
    The present studies were designed to examine the effects of ClC-2 ablation on cellular morphology, parietal cell abundance, H/K ATPase expression, ...
  93. [93]
    The Evolution of Stomach Acidity and Its Relevance to the Human ...
    Gastric acidity is likely a key factor shaping the diversity and composition of microbial communities found in the vertebrate gut.
  94. [94]
    The Microbiota-Gut-Brain Axis | Physiological Reviews
    The importance of the gut-brain axis in maintaining homeostasis has long been appreciated. However, the past 15 yr have seen the emergence of the microbiota ...
  95. [95]
    Relationships among microbiota, gastric cancer, and immunotherapy
    This paper reviewed the relationship between microorganisms and GC, potential links between microorganisms and immunotherapy and research of microorganisms ...Missing: post- | Show results with:post-